BACKGROUND: Abnormalities in traditional lipids, particularly decreased HDL cholesterol and increased triglycerides, can precede the onset of hypertension. Whether lipoprotein particle size or subclass concentrations play a role in the development of hypertension is unknown.
Hypertension is a major risk factor for cardiovascular disease and affects approximately 1 in 3 adults in the US, with direct and indirect costs estimated at $43.5 billion in 2007 (1 ) . Hypertension often clusters with dyslipidemia, especially among individuals with insulin resistance (2 ) . Results of previous studies have demonstrated an increased risk of hypertension with lower concentrations of HDL cholesterol and higher concentrations of LDL cholesterol and triglycerides (3) (4) (5) (6) .
Lipoprotein abnormalities, particularly smaller LDL size and increased concentrations of triglyceriderich particles, may contribute to high blood pressure by impairing endothelial function and promoting insulin resistance and vascular inflammation (7) (8) (9) (10) . It has been recognized that a key feature of insulin resistance is the occurrence of a particular pattern of abnormalities in lipoprotein subclass distributions that is not detected by traditional lipid testing but can be assessed by using advanced lipoprotein testing with techniques such as nuclear magnetic resonance (NMR) 5 spectroscopy of plasma (11 ) . NMR spectroscopy allows the simultaneous determination of both the concentration and size of lipoprotein particles, properties associated with the risk of cardiovascular disease (12) (13) (14) , insulin resistance (8 ) , and diabetes (15 ) . We hypothesized that lipoprotein particle size or subclass abnormalities that are associated with insulin resistance (i.e., smaller size of LDL and HDL particles, and increased concentration of triglyceride-rich particles) would predict incident hypertension. Therefore, in a large prospective cohort of initially healthy women, we evaluated the relationship between incident hypertension and baseline lipoprotein subclass size and concentration of LDL, HDL, and VLDL particles, and how these measures compared with those for traditional lipids and apolipoproteins. We further examined whether the association could be attenuated by biomarkers of inflammation/endothelial function, hyperglycemia, and other risk factors.
Materials and Methods

STUDY POPULATION
Study participants were from the Women's Health Study (WHS), a trial begun in 1992 to study the primary prevention of cardiovascular disease and cancer in initially healthy US female health professionals aged 45 years or older randomized to take vitamin E and aspirin (16, 17 ) . All WHS participants provided written informed consent, and the study was approved by the institutional review board of the Brigham and Women's Hospital (Boston, Massachusetts).
A total of 28 345 WHS participants (71%) provided baseline blood samples. For this study, we excluded 7165 women who were hypertensive at baseline, defined as those who reported a systolic blood pressure Ͼ140 mmHg, a diastolic blood pressure Ͼ90 mmHg, any history of use of blood pressure medications, or any history of a physician diagnosis of hypertension. We further excluded women who were missing information on any lipid or lipoprotein measurements or other covariates, resulting in 17 527 women for this analysis.
LIPIDS AND LIPOPROTEIN MEASURES
EDTA blood samples were obtained at the time of enrollment into the WHS and stored in vapor-phase liquid nitrogen (Ϫ170°C). The frozen plasma specimens were thawed and lipoprotein particle concentrations were measured by proton NMR spectroscopy (LipoScience) (18, 19 ) . NMR signal amplitudes of the spectroscopically distinct lipid methyl group for each lipoprotein were used to calculate concentrations for the different lipoproteins (18 ) . The lipoprotein particles obtained included total HDL, further subdivided into large, medium, and small particles; total LDL, further subdivided into large and small LDL particles and intermediate-density lipoprotein (IDL) particles; and total VLDL, further subdivided into large, medium, and small particles. The IDL particles, sized between VLDL and LDL particles, were categorized with the LDL particles because they exhibit similar properties. Relative mass percentages were multiplied by the diameter of each subclass to obtain weighted mean size for each lipoprotein particle (18, 19 ) . The NMR lipoprotein variables that we examined were those that are provided when ordering a commercially available NMR lipoprotein profile (20 ) . Particle diameters and CVs have been previously published for the NMR measures, with between-run CVs 7.1% or below for all particles except IDL (13%) (20 ) .
All other plasma measurements were analyzed in a core laboratory facility certified by the National Heart, Lung, and Blood Institute/CDC Lipid Standardization Program. Traditional lipid measures used in this study (total, HDL, and LDL cholesterol and triglycerides) were all measured directly with a Hitachi 917 analyzer by using reagents from Roche Diagnostics with between-run CVs Ͻ3%. We measured apolipoproteins B100 (apoB) and apoA-1 by using immunoturbidimetric assays (DiaSorin) with between-run CVs of 5% and 3%, respectively.
HYPERTENSION
Baseline self-reported blood pressure (in mmHg categories of Ͻ110, 110 -119, 120 -129, 130 -139, 140 -149, 150 -159, 160 -169, 170 -179, and Ն180 for systolic blood pressure and Ͻ65, 65-74, 75-84, 85-89, 90 -94, 95-104, and Ն105 for diastolic blood pressure), history of treatment for high blood pressure, and physician diagnosis of hypertension were assessed by questionnaire. Incident hypertension was ascertained with an annual questionnaire by using methods previously described in detail (3 ) . Briefly, participants were classified as hypertensive after reporting either a new physician diagnosis at year 1, 3, or annually thereafter; a new hypertensive treatment at year 1, 3, or 4; a systolic blood pressure of 140 mmHg or greater at year 1 or 4; or a diastolic blood pressure of 90 mmHg or greater at year 1 or 4. The reproducibility of self-reported hypertension status in these female health professionals was assessed in a subsample of participants by using medical records, with high rates of agreement (96% confirmation rate for reports of hypertension and 90% confirmation rate for reports of no hypertension) (21 ) .
COVARIATES
Baseline age, race, diabetes, alcohol use, exercise frequency, treatment for high cholesterol, postmenopausal hormone use, diet, education, smoking, and menopausal status were collected from self-reported questionnaires. Body mass index (BMI) was calculated from self-reported height and weight at baseline. Other markers relating to inflammation and endothelial function, including C-reactive protein, fibrinogen, homocysteine, and soluble intercellular adhesion molecule-1, as well as hemoglobin A 1c concentrations, were also measured as previously described (22 ) .
STATISTICAL METHODS
Logistic models with an outcome of incident hypertension at 8 years were chosen as the primary modeling strategy. Lipid measurements were divided into quin- tiles and were analyzed both categorically and for linear trend across quintiles using quintile number. The primary adjustment for confounding included nonlipid risk factors (baseline values of age, smoking, fasting status, use of cholesterol-lowering medication, trial treatment assignment, hormone use, menopausal status, race, exercise, alcohol use, BMI, diabetes, education, and vegetable, fruit, sodium, and total grain intake). The increase in the likelihood ratio obtained by adding the lipid measurement to the nonlipid risk factors was also derived.
To assess the independent impact of each of the NMR lipoprotein sizes, we examined a fully adjusted model including all 9 lipoprotein subclasses. A fully adjusted model was also examined, for which we used the mean size and particle concentration for each lipoprotein plus nonlipid risk factors. c-Statistics were used to compare the addition of NMR measures to models with nonlipid risk factors and traditional lipids (23 ) . A similar analysis was also performed with standard lipids and apolipoprotein measures plus nonlipid risk factors.
To assess potential mediators, we examined models with additional adjustment for inflammatory/endothelial function markers (C-reactive protein, fibrinogen, homocysteine, and soluble intercellular adhesion molecule-1), hemoglobin A 1c levels, and baseline blood pressure.
All analyses were also redone in designated subgroups and tested for interaction: (a) BMI divided into obese (BMI Ն30), overweight (BMI 25-30), and normal (BMI Ͻ25) (24 ); (b) blood pressure Ͻ120/70 mmHg; (c) metabolic syndrome categories previously used in the WHS (25 ) with and without the blood pressure criterion of Ն130/85 mmHg; and (d) nonusers of lipid-lowering medication.
All analyses were done by using R version 2.10.1 (R Foundation for Statistical Computing).
Results
During 8 years of follow-up, incident hypertension occurred in 4714 study participants (27%). As shown in Table 1 , women who developed hypertension were older at baseline, with higher baseline blood pressures, along with a higher prevalence of hormone use, diabetes, and postmenopausal status. They also exercised less, had a higher BMI, and were more likely to be Black or Hispanic.
Median baseline lipid and lipoprotein measures significantly differed in women who went on to develop hypertension. HDL cholesterol, apoA-1, the concentrations of large LDL and HDL particles, and the mean LDL and HDL particle size were lower in women who developed hypertension. All other lipid and lipoprotein measures were higher in women who developed hypertension. Correlations between the NMR and traditional lipid measures were similar to previously published values for the WHS (12 ), with low correlations between the mean sizes and total particle numbers and low-to-moderate correlations among the 9 particle subclasses.
LDL MEASURES
In unadjusted analysis by quintile of each measure, all LDL measures were associated with hypertension, as shown in Table 2 . After adjustment for nonlipid risk factors (model 1: age, smoking, fasting status, use of cholesterol-lowering medication, trial treatment assignment, hormone use, menopausal status, race, exercise, alcohol use, BMI, diabetes, education, and vegetable, fruit, sodium, and total grain intake), LDL cholesterol was no longer associated. By contrast, apoB and all of the LDL NMR measures remained significantly associated with incident hypertension. Large LDL particle concentration and mean LDL particle size were inversely associated with risk of hypertension, Table 2 ).
HDL MEASURES
All HDL measures were associated with incident hypertension in unadjusted analyses (Table 3) . After adjustment for nonlipid risk factors (model 1), apoA-1 was no longer independently associated, whereas standard HDL cholesterol and all HDL NMR measures remained significantly associated. The total concentration of HDL particles, specifically the medium and small HDL particles which make up most of the total concentration of HDL, were associated with increased risk, whereas large HDL particles were inversely associated with risk of hypertension. Accordingly, larger mean HDL particle size was also associated with decreased incidence of hypertension. The largest odds ratios and likelihood ratios for comparison of quintile 5 to quintile 1 were for HDL particle size (OR 0. Table 3 ).
VLDL AND TRIGLYCERIDE MEASURES
The VLDL and triglyceride measures (Table 4) were all associated with hypertension before adjustment, and all except small VLDL particle concentration remained associated after adjustment for nonlipid risk factors (model 1). In contrast with the association of smaller size of LDL and HDL with hypertension, larger VLDL size and large VLDL particle concentration were asso- Table 4 ).
MUTUALLY ADJUSTED EFFECTS OF LIPOPROTEIN PARTICLE
SUBCLASSES
In a model including quintiles of NMR particle concentrations for the 9 nonoverlapping particle subclasses and nonlipid risk factors, the medium and small HDL particles, the IDL and small LDL particles, and the medium and large VLDL particles remained independently associated with hypertension risk (Fig. 1) . Consistent with the previous results, these particle subclasses, with the exception of medium VLDL particles, were associated with an increased risk of hypertension.
MUTUALLY ADJUSTED EFFECTS OF LIPOPROTEIN PARTICLE CONCENTRATION VS SIZE
When the total particle concentration and mean particle size for each lipoprotein type were combined into one model with nonlipid risk factors, the total concentration of LDL and HDL particles and mean VLDL particle size were each independently associated with increased risk of hypertension (Fig. 2) . These results are consistent with the finding that of the VLDL particles, the large particles were associated with the greatest increase in risk.
ADDING LIPOPROTEINS TO TRADITIONAL LIPIDS
Addition of the 9 particle subclasses improved discrimination over a base model with nonlipid factors and traditional lipids, increasing the c-statistic from 0.671 to 0.676 (P Ͻ 0.001). In a separate analysis, adding the total particle concentration and mean particle size for each lipoprotein type over a base model with nonlipid risk factors and traditional lipids also improved the c-statistic to 0.677 (P ϭ 0.001 for comparison to the base model). Addition of apoA-1 and apoB to the base model did not statistically significantly improve the c-statistic (0.673; P ϭ 0.7), although both apolipoproteins remained independently associated with incident hypertension.
SUBGROUP ANALYSES
Results were similar to the main study results in each of the prespecified subgroup analysis (BMI categories, low baseline blood pressure, presence of metabolic syndrome, and nonusers of cholesterol-lowering medications). In addition, there was no evidence of interactions with any subgroup. The BMI subgroup results are shown in Supplemental Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol57/issue8. Our results also remained similar after additional adjustments for baseline blood pressure.
Discussion
This study involving 17 527 initially healthy women followed prospectively for 8 years is the first to document that the pattern of lipoprotein subclass abnormalities that predicted incident hypertension is the same pattern that has been previously found to be characteristic of insulin resistance and diabetes (i.e., higher concentrations of small LDL, small HDL, and large VLDL particles) (11, 15 ) . In additional, we found that increased total concentrations of LDL, HDL, and VLDL particles were significantly associated with increased risk, and these measures provided additional information over that provided by the traditional lipid panel and other risk factors for hypertension. Postulated mechanisms for the relationship between lipoprotein patterns and incident hypertension include the common pathways of insulin resistance, inflammation, and endothelial dysfunction by increasing the endothelial oxidative burden. (7) (8) (9) (10) 26 ) We explored additional adjustment for inflammation/ endothelial markers, including C-reactive protein, fibrinogen, homocysteine, and soluble intercellular adhesion molecule-1, because some of these biomarkers have been related to incident hypertension (27 ) . Further adjustment for inflammation/endothelial markers did not affect the associations of lipoprotein size and concentrations with hypertension. Similarly, adjustment for hemoglobin A 1c did not alter the results. These findings suggest that the mechanisms of increased hypertension risk associated with lipoprotein abnormalities are unlikely to be mediated by these biomarkers of inflammation/endothelial function or dysglycemia.
Traditional lipid measures have been shown to be associated with increased risk of hypertension in this All ORs are from a single model including NMR measures and nonlipid risk factors. Statistically significant P values were noted for total LDL particles (Ͻ0.001), total HDL particles (Ͻ0.001), mean VLDL particle size (Ͻ0.001), and total VLDL particles (0.033).
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Clinical Chemistry 57:8 (2011) 1185 and other cohorts (3) (4) (5) (6) . In particular, lower HDL cholesterol and higher triglycerides (and in some studies, LDL cholesterol) have been associated with increased risk. Triglycerides and apoB were also shown to be positively associated with an increased risk of hypertension in middle-aged Finnish men (6 ) . Our study confirms these findings for HDL cholesterol, apoB, and triglycerides in this cohort of middle-aged and older women, although we did not find LDL cholesterol to be independently related to incident hypertension.
Previous studies in both this cohort (12, 15 ) and others (13, 14 ) have linked NMR lipoprotein measures to cardiovascular disease and diabetes. Consistent with our results, increased concentration of LDL particles, specifically small particles, has been shown to increase cardiovascular risk as well as risk of incident type 2 diabetes, as has increased concentration of small HDL particles. These patterns are consistent with a shared insulin resistance pathway. We did not have a specific measure for insulin resistance in our study, although adjustment for BMI, triglycerides, hemoglobin A 1c and inflammatory biomarkers did not substantially change the results.
The study benefitted from a large sample size with well-characterized study participants and a long follow-up (8 years). However, because our study was limited to women, the generalizability of our results to men remains unclear, although traditional lipids have been found to be associated with hypertension in both groups. In addition, our measure of hypertension was self-reported. Although this method may have introduced variability into the outcome measure, we believe this variability was unlikely to be related to lipoprotein measures and was therefore unlikely to have affected the direction of our results. The large sample size of the study was also helpful in providing sufficient power to enable us to observe associations despite measurement variability. Self-reported hypertension has been shown to be a valid and reliable measure in this group (28 ) , as well as in other cohorts of health professionals (29 ) .
In summary, we found that among initially healthy women, lipoprotein particle size and subclass concentrations were associated with incident hypertension and provided additive information to traditional lipids and risk factors. Greater risk of hypertension was associated with higher total concentrations of LDL and HDL particles, especially small particles, and higher total concentration of VLDL particles, especially large particles. In addition, our findings suggest that the concentrations and size of lipoprotein particles affect the risk of incident hypertension years before the clinical onset of hypertension, even in women with initially normal blood pressure. Further research is necessary to determine whether treatment based on lipoprotein profiles would reduce incident hypertension. However, the possibility of identification of a subgroup at increased risk for incident hypertension by using lipoprotein measures assessed years before the onset of clinical hypertension may be of use for patients and clinicians. This additional information beyond traditional lipid measures may be useful both in understanding the etiology and in complementing the use of traditional risk factors for predicting the risk of incident hypertension.
